Report Detail

Medical Devices & Consumables Global Artificial Transcatheter Heart Valve Market Research Report 2021

  • RnM4301787
  • |
  • 06 April, 2021
  • |
  • Global
  • |
  • 123 Pages
  • |
  • QYResearch
  • |
  • Medical Devices & Consumables

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Aortic Heart Valve
Mitral Heart Valve
Tricuspid Heart Valve

Segment by Application
Aortic Stenosis
Aortic Regurgitation
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Edwards Lifesciences
Medtronic
Abbott
Livanova
Boston Scientific
Cryolife
Suzhou Jiecheng Medical Technology Co., Ltd.
Labcor Laboratórios Ltda
Braile Biomédica
MicroPort Scientific Corporation
Beijing Balance Medical Technology Co., Ltd.
Myval


1 Artificial Transcatheter Heart Valve Market Overview

  • 1.1 Product Overview and Scope of Artificial Transcatheter Heart Valve
  • 1.2 Artificial Transcatheter Heart Valve Segment by Type
    • 1.2.1 Global Artificial Transcatheter Heart Valve Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Aortic Heart Valve
    • 1.2.3 Mitral Heart Valve
    • 1.2.4 Tricuspid Heart Valve
  • 1.3 Artificial Transcatheter Heart Valve Segment by Application
    • 1.3.1 Artificial Transcatheter Heart Valve Sales Comparison by Application: (2021-2027)
    • 1.3.2 Aortic Stenosis
    • 1.3.3 Aortic Regurgitation
    • 1.3.4 Others
  • 1.4 Global Artificial Transcatheter Heart Valve Market Size Estimates and Forecasts
    • 1.4.1 Global Artificial Transcatheter Heart Valve Revenue 2016-2027
    • 1.4.2 Global Artificial Transcatheter Heart Valve Sales 2016-2027
    • 1.4.3 Artificial Transcatheter Heart Valve Market Size by Region: 2016 Versus 2021 Versus 2027

2 Artificial Transcatheter Heart Valve Market Competition by Manufacturers

  • 2.1 Global Artificial Transcatheter Heart Valve Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Artificial Transcatheter Heart Valve Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Artificial Transcatheter Heart Valve Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Artificial Transcatheter Heart Valve Manufacturing Sites, Area Served, Product Type
  • 2.5 Artificial Transcatheter Heart Valve Market Competitive Situation and Trends
    • 2.5.1 Artificial Transcatheter Heart Valve Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Artificial Transcatheter Heart Valve Players Market Share by Revenue
    • 2.5.3 Global Artificial Transcatheter Heart Valve Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Artificial Transcatheter Heart Valve Retrospective Market Scenario by Region

  • 3.1 Global Artificial Transcatheter Heart Valve Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Artificial Transcatheter Heart Valve Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Artificial Transcatheter Heart Valve Market Facts & Figures by Country
    • 3.3.1 North America Artificial Transcatheter Heart Valve Sales by Country
    • 3.3.2 North America Artificial Transcatheter Heart Valve Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Artificial Transcatheter Heart Valve Market Facts & Figures by Country
    • 3.4.1 Europe Artificial Transcatheter Heart Valve Sales by Country
    • 3.4.2 Europe Artificial Transcatheter Heart Valve Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Artificial Transcatheter Heart Valve Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Artificial Transcatheter Heart Valve Sales by Region
    • 3.5.2 Asia Pacific Artificial Transcatheter Heart Valve Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Artificial Transcatheter Heart Valve Market Facts & Figures by Country
    • 3.6.1 Latin America Artificial Transcatheter Heart Valve Sales by Country
    • 3.6.2 Latin America Artificial Transcatheter Heart Valve Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Artificial Transcatheter Heart Valve Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Artificial Transcatheter Heart Valve Sales by Country
    • 3.7.2 Middle East and Africa Artificial Transcatheter Heart Valve Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Artificial Transcatheter Heart Valve Historic Market Analysis by Type

  • 4.1 Global Artificial Transcatheter Heart Valve Sales Market Share by Type (2016-2021)
  • 4.2 Global Artificial Transcatheter Heart Valve Revenue Market Share by Type (2016-2021)
  • 4.3 Global Artificial Transcatheter Heart Valve Price by Type (2016-2021)

5 Global Artificial Transcatheter Heart Valve Historic Market Analysis by Application

  • 5.1 Global Artificial Transcatheter Heart Valve Sales Market Share by Application (2016-2021)
  • 5.2 Global Artificial Transcatheter Heart Valve Revenue Market Share by Application (2016-2021)
  • 5.3 Global Artificial Transcatheter Heart Valve Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Edwards Lifesciences
    • 6.1.1 Edwards Lifesciences Corporation Information
    • 6.1.2 Edwards Lifesciences Description and Business Overview
    • 6.1.3 Edwards Lifesciences Artificial Transcatheter Heart Valve Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Edwards Lifesciences Product Portfolio
    • 6.1.5 Edwards Lifesciences Recent Developments/Updates
  • 6.2 Medtronic
    • 6.2.1 Medtronic Corporation Information
    • 6.2.2 Medtronic Description and Business Overview
    • 6.2.3 Medtronic Artificial Transcatheter Heart Valve Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Medtronic Product Portfolio
    • 6.2.5 Medtronic Recent Developments/Updates
  • 6.3 Abbott
    • 6.3.1 Abbott Corporation Information
    • 6.3.2 Abbott Description and Business Overview
    • 6.3.3 Abbott Artificial Transcatheter Heart Valve Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Abbott Product Portfolio
    • 6.3.5 Abbott Recent Developments/Updates
  • 6.4 Livanova
    • 6.4.1 Livanova Corporation Information
    • 6.4.2 Livanova Description and Business Overview
    • 6.4.3 Livanova Artificial Transcatheter Heart Valve Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Livanova Product Portfolio
    • 6.4.5 Livanova Recent Developments/Updates
  • 6.5 Boston Scientific
    • 6.5.1 Boston Scientific Corporation Information
    • 6.5.2 Boston Scientific Description and Business Overview
    • 6.5.3 Boston Scientific Artificial Transcatheter Heart Valve Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Boston Scientific Product Portfolio
    • 6.5.5 Boston Scientific Recent Developments/Updates
  • 6.6 Cryolife
    • 6.6.1 Cryolife Corporation Information
    • 6.6.2 Cryolife Description and Business Overview
    • 6.6.3 Cryolife Artificial Transcatheter Heart Valve Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Cryolife Product Portfolio
    • 6.6.5 Cryolife Recent Developments/Updates
  • 6.7 Suzhou Jiecheng Medical Technology Co., Ltd.
    • 6.6.1 Suzhou Jiecheng Medical Technology Co., Ltd. Corporation Information
    • 6.6.2 Suzhou Jiecheng Medical Technology Co., Ltd. Description and Business Overview
    • 6.6.3 Suzhou Jiecheng Medical Technology Co., Ltd. Artificial Transcatheter Heart Valve Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Suzhou Jiecheng Medical Technology Co., Ltd. Product Portfolio
    • 6.7.5 Suzhou Jiecheng Medical Technology Co., Ltd. Recent Developments/Updates
  • 6.8 Labcor Laboratórios Ltda
    • 6.8.1 Labcor Laboratórios Ltda Corporation Information
    • 6.8.2 Labcor Laboratórios Ltda Description and Business Overview
    • 6.8.3 Labcor Laboratórios Ltda Artificial Transcatheter Heart Valve Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Labcor Laboratórios Ltda Product Portfolio
    • 6.8.5 Labcor Laboratórios Ltda Recent Developments/Updates
  • 6.9 Braile Biomédica
    • 6.9.1 Braile Biomédica Corporation Information
    • 6.9.2 Braile Biomédica Description and Business Overview
    • 6.9.3 Braile Biomédica Artificial Transcatheter Heart Valve Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Braile Biomédica Product Portfolio
    • 6.9.5 Braile Biomédica Recent Developments/Updates
  • 6.10 MicroPort Scientific Corporation
    • 6.10.1 MicroPort Scientific Corporation Corporation Information
    • 6.10.2 MicroPort Scientific Corporation Description and Business Overview
    • 6.10.3 MicroPort Scientific Corporation Artificial Transcatheter Heart Valve Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 MicroPort Scientific Corporation Product Portfolio
    • 6.10.5 MicroPort Scientific Corporation Recent Developments/Updates
  • 6.11 Beijing Balance Medical Technology Co., Ltd.
    • 6.11.1 Beijing Balance Medical Technology Co., Ltd. Corporation Information
    • 6.11.2 Beijing Balance Medical Technology Co., Ltd. Artificial Transcatheter Heart Valve Description and Business Overview
    • 6.11.3 Beijing Balance Medical Technology Co., Ltd. Artificial Transcatheter Heart Valve Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Beijing Balance Medical Technology Co., Ltd. Product Portfolio
    • 6.11.5 Beijing Balance Medical Technology Co., Ltd. Recent Developments/Updates
  • 6.12 Myval
    • 6.12.1 Myval Corporation Information
    • 6.12.2 Myval Artificial Transcatheter Heart Valve Description and Business Overview
    • 6.12.3 Myval Artificial Transcatheter Heart Valve Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Myval Product Portfolio
    • 6.12.5 Myval Recent Developments/Updates

7 Artificial Transcatheter Heart Valve Manufacturing Cost Analysis

  • 7.1 Artificial Transcatheter Heart Valve Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Artificial Transcatheter Heart Valve
  • 7.4 Artificial Transcatheter Heart Valve Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Artificial Transcatheter Heart Valve Distributors List
  • 8.3 Artificial Transcatheter Heart Valve Customers

9 Artificial Transcatheter Heart Valve Market Dynamics

  • 9.1 Artificial Transcatheter Heart Valve Industry Trends
  • 9.2 Artificial Transcatheter Heart Valve Growth Drivers
  • 9.3 Artificial Transcatheter Heart Valve Market Challenges
  • 9.4 Artificial Transcatheter Heart Valve Market Restraints

10 Global Market Forecast

  • 10.1 Artificial Transcatheter Heart Valve Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Artificial Transcatheter Heart Valve by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Artificial Transcatheter Heart Valve by Type (2022-2027)
  • 10.2 Artificial Transcatheter Heart Valve Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Artificial Transcatheter Heart Valve by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Artificial Transcatheter Heart Valve by Application (2022-2027)
  • 10.3 Artificial Transcatheter Heart Valve Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Artificial Transcatheter Heart Valve by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Artificial Transcatheter Heart Valve by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    Summary:
    Get latest Market Research Reports on Artificial Transcatheter Heart Valve. Industry analysis & Market Report on Artificial Transcatheter Heart Valve is a syndicated market report, published as Global Artificial Transcatheter Heart Valve Market Research Report 2021. It is complete Research Study and Industry Analysis of Artificial Transcatheter Heart Valve market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,250.40
    3,375.60
    4,500.80
    2,702.80
    4,054.20
    5,405.60
    447,441.00
    671,161.50
    894,882.00
    244,528.00
    366,792.00
    489,056.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report